hat
IV Fosaprepitant 115 mg nan jou 1 sèlman kòm yon perfusion sou minit 15, minit 30 anvan chimyoterapi. Apapitant 125 mg oralman ka ranplase pou fosaprepitant 115 mg IV nan jou 1. Apwopriye 80 mg aloral ta dwe administre nan jou 2 ak 3. Administre an konjonksyon avèk yon kortikoterapi (dexamethasone 12 mg oralman minit 30 anvan chimyoterapi nan jou 1) ak yon 5-HT antagonist 3 (Ondansetron 8 mg oralman 30 minit 60 anvan chimyoterapi ak 8 h apre premye dòz la nan jou 1) .150 mg piki (yon sèl-dòz rejim)
eng
IV Fosaprepitant 115 mg on day 1 only as an infusion over 15 minutes, 30 minutes prior to chemotherapy. Aprepitant 125 mg orally may be substituted for fosaprepitant 115 mg IV on day 1. Aprepitant 80 mg orally should be administered on days 2 and 3. Administer in conjunction with a corticosteroid (dexamethasone 12 mg orally 30 minutes prior to chemotherapy on day 1) and a 5-HT 3 antagonist (ondansetron 8 mg orally 30 to 60 minutes prior to chemotherapy and 8 h after the first dose on day 1).150 mg injection (single-dose regimen)